SpringWorks Therapeutics Shares 2011-2026 | SWTX

Annual Shares SpringWorks Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
74.1 M	63.1 M	53.3 M	48.5 M	43.3 M	13.3 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
74.1 M	13.3 M	49.3 M

Quarterly Shares SpringWorks Therapeutics

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
74.9 M	74.4 M	74.3 M	74.1 M	73.8 M	73.5 M	62.5 M	62.5 M	62.3 M	62.4 M	52.9 M	49.1 M	48.9 M	49.2 M	48.6 M	48.4 M	48.2 M	48.8 M	42.1 M	41.9 M	41.8 M	43 M	9.49 M	879 K	680 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
74.9 M	680 K	50.8 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
ACADIA Pharmaceuticals ACAD	166 M	$ 22.56	2.13 %	$ 3.74 B	USA
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	84.2 M	-	-	$ 8.42 M	USA
Akebia Therapeutics AKBA	257 M	$ 1.43	3.62 %	$ 368 M	USA
argenx SE ARGX	51.1 M	$ 785.07	2.57 %	$ 25 B	Niderland
I-Mab IMAB	187 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Alnylam Pharmaceuticals ALNY	131 M	$ 327.25	2.42 %	$ 42.9 B	USA
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Aytu BioScience AYTU	6.28 M	$ 2.66	3.5 %	$ 16.7 M	USA
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	1.42 B	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	2.41 B	$ 3.9	3.7 %	$ 9.38 B	Australia
CymaBay Therapeutics CBAY	106 M	-	-	$ 3.45 B	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	46.7 M	$ 20.4	-0.87 %	$ 954 M	USA
Aquestive Therapeutics AQST	107 M	$ 4.18	1.21 %	$ 447 M	USA
Avid Bioservices CDMO	63.2 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	6.35 M	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Arcutis Biotherapeutics ARQT	127 M	$ 24.61	5.76 %	$ 3.13 B	USA
Cabaletta Bio CABA	100 M	$ 3.09	0.65 %	$ 310 M	USA
Checkpoint Therapeutics CKPT	39.7 M	-	-	$ 169 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	21.6 M	-	-	$ 231 M	USA
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	34.4 M	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Autolus Therapeutics plc AUTL	266 M	$ 1.49	9.56 %	$ 397 M	Britain
CTI BioPharma Corp. CTIC	115 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	2.19 M	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	85.1 M	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	130 M	-	-	$ 2.02 B	USA
Forte Biosciences FBRX	12.9 M	$ 26.27	0.38 %	$ 340 M	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Akari Therapeutics, Plc AKTX	67.3 B	$ 3.88	2.11 %	$ 261 B	Britain
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA